Tag: Long COVID
-
Groundbreaking Blood Test for Chronic Fatigue Syndrome Could Transform Diagnosis
Overview: A Potential Breakthrough in ME/CFS Diagnosis A team of researchers from the University of East Anglia has unveiled what they describe as the first-ever blood test capable of diagnosing chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME). The test demonstrates an overall accuracy of 96% in distinguishing people with ME/CFS from healthy…
-
Scientists unveil first blood test to diagnose chronic fatigue syndrome with 96% accuracy
Groundbreaking Blood Test for ME/CFS Arrives A new blood test claims to diagnose chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), with an impressive overall accuracy of 96%. Developed by researchers at the University of East Anglia, the test analyzes how DNA is folded in blood samples to detect unique epigenetic patterns associated…
-
New Workout Friends in the Post-COVID Aftermath
New Sportmates in the Post-COVID Aftermath My heart and blood vessels have become the fragile frontiers of aging. For more than three years a coronary angiography showed my arterioles letting through less blood than normal and that the peripheral resistance in the heart’s vascular tree was high. Lisbeth, 87, has traded her once-fierce long runs…
-
Post-Covid: New sport mates and lingering symptoms today
Post-Covid and the new everyday heroes Three years into the pandemic, my heart and vascular health are no longer the only limits. A coronary angiogram showed my arterioles letting through less blood than normal, and peripheral resistance in the heart’s vascular tree was high. I’ve had to reinvent my life around what my body can…
-
New Sport Partners in the COVID Aftermath: A Swedish Long-COVID Story
Post-COVID Realities in Sweden: A Personal Account In Sweden, a growing number of people navigate life after the initial waves of the pandemic, not with a single diagnosis but with a constellation of lingering symptoms. The narrator, once a man defined by his stamina, finds his heart and vascular system no longer reliable. Tasks as…
-
New findings tie Long COVID brain fog to AMPA receptor changes
Overview: Long COVID brain fog and a search for molecular clues Long COVID has emerged as one of the most persistent health challenges of the post-pandemic era. Among its most troubling consequences is cognitive impairment, commonly referred to as “brain fog,” which disrupts memory, attention, and problem-solving for many patients. While neuroimaging has revealed structural…
-
Unraveling Long COVID Brain Fog: AMPA Receptors Spotlighted by PET Imaging
New Molecular Insight into Long COVID Brain Fog As the world continues to grapple with the consequences of SARS-CoV-2 infection, Long COVID — a condition characterized by lingering symptoms after the acute illness — remains poorly understood. Among the most disabling manifestations is cognitive impairment, colloquially known as brain fog, which affects a significant portion…
-
Molecular Basis of Long COVID Brain Fog Revealed by AMPAR PET Imaging
Groundbreaking findings illuminate the biology of Long COVID brain fog In a landmark study led by Professor Takuya Takahashi at Yokohama City University, researchers used a novel PET imaging approach to visualize AMPA receptors (AMPARs) in living brains. The team compared 30 patients suffering from Long COVID with 80 healthy controls and found a systemic…
-
Metformin’s Role in Reducing Long COVID Risk: Insights from a UK Study
Introduction to Metformin and Long COVID In a groundbreaking study conducted in the UK, researchers have found that metformin, a common drug typically used to manage diabetes, has the potential to reduce the risk of Long COVID by an impressive 64% in overweight individuals. This revelation not only sheds light on the repurposing of existing…
-
Metformin Reduces Long COVID Risk: Key Insights from UK Study
Introduction In a groundbreaking UK study, researchers have uncovered that Metformin, a widely used and affordable diabetes medication, can significantly lower the risk of Long COVID by a remarkable 64%. This finding particularly highlights the potential benefits for overweight individuals who are already at higher risk of severe COVID-19 outcomes. With Long COVID affecting countless…